The cGAS/STING pathway activation contributes to sensitization of cancer cells to radio- and chemotherapy (Parkes et al., 2017; Li and Chen, 2018; Chen et al., 2020) also reviewed in (Hayman and Glazer, 2021), and to their proliferative capacity (Ranoa et al., 2018); furthermore, STING or cGAS are often mutated or silenced in cancer cells (Sun et al., 2013; Xia et al., 2016; Deschamps and Kalamvoki, 2017; Song et al., 2017; de Queiroz et al., 2018). This evidence concerns the gene CGAS and cancer.